CARNEGIE-MELLON UNIVERSITY: $11.4M Department of Health and Human Services Federal Award
Summary
The NIH awarded a $11.4M research grant to Carnegie-Mellon University for fetal hypoxia assessment technology. As a private educational institution, no publicly-traded companies are directly impacted.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.No publicly-traded companies are linked to this award, so direct market impact is absent.
- 2.The $11.4M is a modest research grant focused on fetal health diagnostics, not a commercial contract.
- 3.Investors should monitor future licensing or spin-off activity from Carnegie-Mellon's research for potential public market exposure.
Market Implications
This contract has no material market implications. The award is a standard academic research grant with no commercial production or procurement component. No tickers are affected.
Full Analysis
This contract is a Direct Payment for Specified Use from the National Institutes of Health (NIH) to Carnegie-Mellon University, totaling $11.4M over two years (2026-2028). The award funds the OMEGA (Optical, Mechanical, and Electrical Global Assessment of Fetal Hypoxia) project, which aims to develop multi-modal sensing technologies for early detection of fetal oxygen deprivation. Carnegie-Mellon is a private university, not a publicly-traded entity, so there is no direct public company beneficiary. The research is in the early-stage development phase, typical for academic medical grants. No related legislation in the provided bill signals directly authorizes or appropriates funds for this specific research line, so no legislative tailwinds apply. Supply chain and competitive displacement effects are negligible at this stage, as the contract does not involve commercial production or procurement of medical devices. Historically, NIH research grants to universities rarely have near-term implications for publicly-traded companies unless the technology is licensed to a commercial entity later.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.2B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Contract Details
Recipient
CARNEGIE-MELLON UNIVERSITY
Award Amount
$11,437,452
Awarding Agency
Department of Health and Human Services
Sub-Agency
National Institutes of Health
Contract Type
DIRECT PAYMENT FOR SPECIFIED USE, AS A SUBSIDY OR OTHER NON-REIMBURSABLE DIRECT FINANCIAL AID (C)
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →